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Context: The pathogenesis of autoimmune Addison’s disease (AAD) is thought to be due to in-
terplay of genetic, immune, and environmental factors. A month-of-birth effect, with increased
risk for those born in autumn/winter months, has been described in autoimmune conditions such
as type 1 diabetes and autoimmune thyroid disease.
Objective: Month-of-birth effect was investigated in 2 independent cohorts of AAD subjects.
Design, Setting, and Patients: The monthly distribution of birth in AAD patients was compared
with that of the general population using the cosinor test. A total of 415 AAD subjects from the
United Kingdom cohort were compared with 8 180 180 United Kingdom births, and 231 AAD
subjects from the Polish cohort were compared with 2 421 384 Polish births.
Main Outcome Measures: Association between month of birth and the susceptibility to AAD.
Results: In the entire cohort of AAD subjects, month-of-birth distribution analysis showed signif-
icant periodicitywith peakof births inDecember and trough inMay (P .028). Analysis of theodds
ratio distribution based on month of birth in 2 cohorts of patients with AAD versus the general
population revealed a December peak and May trough, and January peak and July trough, in the
United Kingdom and Polish cohorts, respectively.
Conclusion: For the first time, we demonstrate that month of birth exerts an effect on the risk of
developingAAD,with excess risk in individuals born inwintermonths andaprotective effectwhen
born in the summer. Exposure to seasonal viral infections in the perinatal period, coupled with
vitamin D deficiency, could lead to dysregulation of innate immunity affecting the risk of devel-
oping AAD. (J Clin Endocrinol Metab 101: 4214–4218, 2016)
Autoimmune Addison’s disease (AAD) is a rare disorderwith a reported prevalence of 93–140 per million (1).
Its pathogenesis remains incompletely understood and
is thought to be due to a complex interplay between
genetic, immune, and environmental factors (2). Al-
though a number of susceptibility alleles for the disease
have been identified to date, data on the environmental
factors implicated in the pathophysiology are com-
pletely lacking (3–8).
AAD often occurs with other organ-specific autoim-
mune disorders; among the most prevalent are autoim-
mune thyroid disease, type 1 diabetes and vitiligo (9).
Given the strong association between these disorders, it
can be postulated that they share a common trigger for an
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autoimmune process directed against different tissue-spe-
cific autoantigens.
A month-of-birth effect has been described in a num-
ber of autoimmune disorders, including type 1 diabetes
(10) and autoimmune thyroid disease; however, con-
flicting data regarding the latter have recently emerged
(11, 12).
Oneof the proposed links between an individual’s birth
month and an autoimmune diathesis later in life is season-
related environmental exposure, or lack thereof, in the
perinatal period. According to the fetal origins of adult
disease hypothesis, adverse in utero environmental expo-
sure can lead to maladaptive responses which result in
alterations in organ- and tissue-specific functions, which
may increase the risk of adult disease (13). Among the
important environmental factors that exhibit seasonal
variability and which may be implicated in the develop-
ment of autoimmunity are viral infections (14), UVB ra-
diation and vitamin D3 exposure (15, 16), maternal nu-
trition (16), allergen exposure (17), and air pollution (18).
To our knowledge, there are no data relating to a po-
tential month-of-birth effect in AAD.We sought to ascer-
tain whether such an association existed and, if so,
whether a seasonal predilection for the development of
AAD could provide the basis for an exploration of poten-
tial environmental underpinning for the condition.
Subjects and Methods
Month-of-birth effect was analyzed in United Kingdom and Pol-
ish cohorts of patients with AAD.
The diagnosis of AAD was based on typical symptoms and
signs, confirmed by either the subject having a low basal cortisol
with a high adrenocorticotrophic hormone concentration or a
subnormal response to the short synacthen test (250 mcg par-
enteral synthetic adrenocorticotrophic hormone1–24). In most
patients, autoimmune etiologywas confirmedby thedetectionof
21-hydroxylase antibodies, or antiadrenal antibodies in cases
withmore longstandingdiagnosis. Patientswithprimaryadrenal
failure due to adrenal gland infiltration or infection, bilateral
adrenalectomies, congenital adrenal hyperplasia, or with sec-
ondary adrenal failure were excluded from this study.
The data for the UnitedKingdom cohort were extracted from
a local database at the Institute of Genetic Medicine, Newcastle
University. The United Kingdom cohort comprised 415 patients
with AAD (312 females and 103 males). This cohort included
patients who were recruited through local endocrinology clinics
in the North East region and patients from other regions of
United Kingdom who responded to an invitation, via the Addi-
son’s Disease Self-Help Group, to participate in research at the
Institute of Genetic Medicine in Newcastle. The data were com-
pared with the pattern of total live births for England andWales
during 1963–1972 (n 8 180 180). Demographic information
was obtained from the Office for National Statistics.
The data for the Polish cohort were extracted from the pa-
tients’ records at theDepartment of Endocrinology,Metabolism
and Internal Medicine, Poznan University of Medical Sciences.
ThePolish cohort comprised231AADpatients (167 females and
64males) attending the University Hospital and other endocrine
clinics in the Wielkopolska region. The control data regarding
total live births in Polandwere derived from the Polish Statistical
Annals for the years 1980, 1990, 2000, 2010, and 2012 (n 
2 421 384).
Data regarding year of birth, year of AAD diagnosis, and the
age at diagnosis are presented in Table 1; 46% and 27% of
subjects had isolated AAD in the United Kingdom and Polish
cohorts, respectively. The reminder had at least one other auto-
immune condition. Data regarding these conditions are pre-
sented in Table 2, these data were not available for 5 patients
from the polish cohort.
This study was carried out with approval of the Leeds East
Ethics Committee (reference number 05/Q1206/144) and the
ethical committee at Poznan University of Medical Sciences
(decision 457/14).
Statistical analysis was conducted using SPSS Version 22 and
R (19)using thepackage season.Month-by-monthvariationwas
screened for using X2, with odds ratios (ORs) and 95% confi-
dence intervals (CIs) calculated, to compare the birth rates for
each month in subjects with AAD and the control population.
Table 1. Patient Characteristics
AAD Cohort
Gender
(F/M) Year of Birtha Year of Diagnosisa
Age at
Diagnosisa
United Kingdom 312/103 1953 (1914–2002) 1996 (1948–2015) 38 (10–83)
Polish 167/64 1967 (1924–1996) 1999 (1954–2014) 36 (9–81)
a Data expressed as median with ranges.











Isolated AAD 192 (46) 60 (27)
Autoimmune thyroid disease 167 (40) 156 (69.6)
Hashimoto thyroiditis 132 (32) 123 (54.9)
Graves’ disease 35 (8.4) 33 (14.7)
Chronic atrophic gastritis 
pernicious anaemia
18 (4.4) 27 (12.1)
Type 1 diabetes 25 (6) 22 (9.8)
Celiac disease 8 (1.9) 3 (1.3)
Hypergonadotrophic
hypogonadism
42 (10) 15 (6.7)
Vitiligo 15 (3.6) 14 (6.3)
Alopecia No data 4 (1.8)
Rheumatoid arthritis 8 (1.9) No data
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This analysis was performed separately for the United Kingdom
and polish cohorts. Logistic regression fitting a cosinor model
was used to estimate the annual seasonal trend in the month-of-
birth distribution across all 12 months (20, 21).
Results
To assess whether month of birth influences susceptibility
to AAD, we compared the distribution of month of birth
in all patients with AAD with that of the control popula-
tion. Using the cosinor test, a significant signal for peri-
odicity was observed after adjustment for gender and
country of origin (P  .028). When the cohorts were an-
alyzed separately, this signal retained its significance in the
Polish cohort only (P  .042). AAD patients showed a
peak of births in December and nadir in June.
WhenmonthlyORswere calculated, an increasedbirth rate
in December (P  .029, OR 1.41, 95% CI 1.035–1.92) and
reduced birth rate in May (P .019, OR 0.61, 95%CI 0.4–
0.93)wasdetected in theUnitedKingdomAADcohort (Figure
1B)comparedwith thegeneralUnitedKingdompopulation. In
a gender-stratified analysis, a statistically significant peak was
found in December only in the United Kingdom female AAD
subjects (P .032, OR 1.47, 95%CI 1.03–2.01).
In the Polish AAD cohort, an increased birth rate in
January (P  .04, OR 1.5, 95% CI 1.02–2.1) and de-
creased birth rate in July (P  .046, OR 0.56, 95% CI
0.31–0.99) was detected (Figure 1D) compared with the
general polish population. In a gender-stratified analysis,
a statistically significant peak was found in January only
in the Polish femaleAADsubjects (P .009,OR1.8, 95%
CI 1.15–2.73).
In order to assess the possible effect of latitude on the
seasonality of birth in AAD, we divided the entire cohort
into 2 groups according to latitude. A latitude of 52°
North was chosen, because it provided a reasonable bi-
section of both cohorts. The highest and the lowest
monthly ORs were found north of 52° latitude; however,
95% CIs were overlapping, indicating no significant dif-
ference (Supplemental Figure 1).
Discussion
To our knowledge, this is the first report of a month-of-
birth effect on the risk of developing autoimmune AAD.
Our study showed similar trends in seasonality patterns
for 2 independent cohorts of patients with AAD. There
were a smaller number of AAD subjects born in summer
months, with a nadir inMay for the United Kingdom and
July for Polish subjects, and a greater number of AAD
subjects born in winter months, with a peak in December
in the United Kingdom, and January in the Polish cohort.
Although in the United Kingdom
AAD cohort there is some heteroge-
neity in monthly ORs, this is not sta-
tistically significant and likely repre-
sents a stochastic effect in a dataset
that becomes smaller when split in
12 ways. When looking at fluctua-
tions across all 12 months in the en-
tire cohort of patients, a similar pat-
tern with a trough in summer and
peak in winter was observed. This is
the first studyof this kindandas such
is exploratory in nature and war-
rants further interrogation in other
cohorts of AAD subjects.
The month-of-birth effect in im-
mune mediated diseases has been
long explored and a number of such
studies show a reverse pattern of
seasonality with a peak in spring/
summer and a trough in autumn/
winter (15, 22).However, a number
of studies on autoimmune conditions
commonly associated with AAD re-
ported similar patterns to that ob-
served in our study, with a peak in
Figure 1. A, Month-of-birth distribution for the United Kingdom cohort. B, Odds ratio (OR)
distribution with 95% confidence intervals (CI) based on month of birth in United Kingdom AAD
patients vs general population. A significant peak in December (P  .029) and a trough in May
(P  .019) can be observed. C, Month-of-birth distribution for the Polish cohort. D, OR
distribution with 95% CI based on month of birth in Polish AAD patients vs general population.
A significant peak in January (P  .04) and a trough in July (P  .046) can be observed.
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the number of births observed in autumn and winter in
populations of patients with Graves’ hyperthyroidism and
Hashimoto’s hypothyroidism (11, 12). It is plausible that
in different autoimmune diseases various environmental
triggers play a role during different stages of gestational
and early postnatal development to influence disease sus-
ceptibility later in life.
Our findings mirror the observation that the peak in
type 1 diabetes incidence occurs in autumn and winter
months, which has been linked to the increase in viral
infections observedduring this periodof year (23).Anum-
ber of viral infections such as norovirus, rotavirus, influ-
enza and respiratory syncytial virus exhibit marked win-
tertime seasonality (24). Innate immunity is concerned
with the defense of the host from infection and has been
implicated in the pathophysiology of AAD. A number of
susceptibility loci forAAD in the innate immunepathways
have been discovered including NLRP1, CLEC16A,
VDR, and CYP27B1 (4, 25–27). In addition, experimen-
tal data also support the role of innate immunity in the
pathophysiology of AAD (28). It is plausible that early
primingof immunecells and immunemechanisms induced
by exposure to various (seasonally influenced) pathogens
can influence disease risk in individuals who carry multi-
ple other susceptibility alleles. Although most patients
with AAD are diagnosed between the third and fifth de-
cades of life, this disorder is known to have prolonged
subclinical phase lasting for many years (29, 30). This
raises the possibility that a similar, seasonally influenced
infective trigger may be implicated in its pathogenesis but
with a longer clinical latency than type 1 diabetes.
One of the postulatedmechanisms explaining amonth-
of-birth effect in autoimmune disease is the role that vi-
tamin D deficiency might play in the pathophysiology of
such diseases (31). Several reports have demonstrated that
1,25-dihydroxyvitamin D signaling regulates both innate
and adaptive immunity in humans (32). This hypothesis is
particularly plausible in the case of AAD because of the
known association of the disease with polymorphisms
in both the vitamin D receptor (VDR) gene and the
CYP27B1 gene encoding 1--hydroxylase converting 25-
hydroxyvitamin D into its active form 1,25-dihydroxyvi-
tamin D (8, 27, 33). To explore the possible effect of UVB
radiation exposure, which is known to influence vitamin
D status, on the seasonality pattern observed in AAD, we
comparedmonthly ORs (Supplemental Figure 1) dividing
the cohort into 2 groups according to geographical lati-
tude. Although the effect of seasonality seemed to bemore
pronounced above 52°North, this did not reach statistical
significance. Further studies are required to investigate the
association of perinatal vitamin D status and the risk for
AAD. Verifying vitamin D deficiency and AAD risk by
ascertaining 25 (OH)D status in infancy, however, will be
difficult given the rarity of the condition and the fact that
diagnosis is usually made in individuals in their third to
fifth decade.
We acknowledge there are potential limitations to our
study. Firstly, given the inherent rarity of this condition,
our sample size is relatively small. This could potentially
limit the ability to detect differences, particularly in rela-
tion to the subgroup analysis. Nonetheless, ours repre-
sents one of the largest cohorts of this condition published
to date. Secondly, the subjects in our study were not re-
cruited from a formal national or regional registry, which
could potentially lead to bias, although we feel that this is
unlikely and that thedescribed trend in seasonality is a true
finding, given the similar pattern in 2 independent cohorts
of patients recruited in 2 different countries. Further stud-
ies in large cohorts of AAD patients looking at an associ-
ation of month of birth and the risk of development of the
disease would be useful.
Lastly, our controls obtained from the Office for Na-
tional Statistics and the Polish StatisticalAnnals inevitably
include subjects with AAD. However, given the rarity of
the disease, the expected number of AAD cases in the con-
trol population would be very small and would not influ-
ence the overall result.
In conclusion, our study demonstrates that month of
birth exerts an effect on the risk of developing AAD, with
excess risk in individuals born in winter months and a
protective effect when born in the summer. This is the first
such environmental influence documented in the patho-
genesis of AAD. Exposure to seasonal viral infections in
the perinatal period coupled with vitamin D deficiency
leading to dysregulation of innate immunity could be the
potential initial triggers for the eventual development of
AAD, although this requires further exploration.
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